A molecular residual disease (MRD) assay designed for cancer detection and monitoring.

Tool: Signatera
Description: A molecular residual disease (MRD) assay designed for cancer detection and monitoring.
Summary: Signatera is a highly sensitive, personalized MRD test that detects circulating tumor DNA (ctDNA) in the blood. It is tailored to the unique genetic makeup of an individual's tumor, allowing for the early detection of cancer recurrence and the monitoring of treatment response. This non-invasive test offers a way to identify minimal residual disease with high precision, providing valuable insights for personalized treatment planning.
Category: Cancer Detection
Tags: Diagnostics, Precision Medicine, Cancer Detection, Screening
Use Cases: Monitoring treatment efficacy in cancer patients by detecting ctDNA levels over time.; Early detection of cancer recurrence post-treatment through personalized ctDNA analysis.
Platform: Web
Vendor: Natera
Target Users: Clinician
Pricing: unclear
Regulatory: not a medical device
Meta: Signatera by Natera is a personalized MRD test for detecting and monitoring cancer using circulating tumor DNA analysis.
Content: [Skip navigation](https://www.natera.com/#et-main-area) [Pay Bill](https://pay.natera.com/) [Portals](https://www.natera.com/natera-portal-hub/) [![Home](https://www.natera.com/wp-content/themes/natera/assets/images/logo.svg)](https://www.natera.com/) - Our Tests - [![menu cancer icon](https://www.natera.com/wp-content/uploads/menu/menu-cancer.svg)Oncology](https://www.natera.com/oncology/) - TESTS - [Signatera – Residual Disease Test (MRD)](https://www.natera.com/oncology/signatera-advanced-cancer-detection/) - [Latitude – Tissue Free MRD](https://www.natera.com/oncology/latitude-tissue-free-mrd/) - [Altera – Tumor Genomic profile](https://www.natera.com/oncology/signatera-advanced-cancer-detection/clinicians/altera/) - [Empower – Hereditary Cancer Test](https://www.natera.com/oncology/empower-hereditary-cancer-test/) - FOR PATIENTS - [Signatera Patient Information](https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/) - [Altera Patient Information](https://www.natera.com/oncology/altera/patients/) - [Empower Patient Information](https://www.natera.com/oncology/empower-hereditary-cancer-test/patients/#precisioncare) - [Pricing and Billing Information](https://www.natera.com/oncology/billing/) - FOR CLINICIANS - [Signatera Clinician Information](https://www.natera.com/oncology/signatera-advanced-cancer-detection/clinicians/) - [Altera Clinician Information](https://www.natera.com/oncology/signatera-advanced-cancer-detection/clinicians/altera/) - [Empower Clinician Information](https://www.natera.com/oncology/empower-hereditary-cancer-test/clinicians/#precisioncare) - [Oncology Portal](https://oncology.natera.com/) - [Signatera Research Pipeline](https://www.natera.com/oncology/signatera-advanced-cancer-detection/research-pipeline/) - [![menu renal health icon](https://www.natera.com/wp-content/uploads/menu/menu-renal-health.svg)Organ Health](https://www.natera.com/organ-health/) - TESTS - [Prospera Kidney – Transplant Assessment](https://www.natera.com/organ-health/prospera-organ-transplantation-assessment/) - [Prospera Heart – Transplant Assessment](https://www.natera.com/organ-health/prospera-heart-transplantation-assessment/) - [Prospera Lung – Transplant Assessment](https://www.natera.com/organ-health/prospera-lung-transplantation-assessment/) - [Renasight – Kidney Gene Panel](https://www.natera.com/organ-health/renasight-genetic-testing/) - FOR PATIENTS - [Prospera for Kidney Patients](https://www.natera.com/organ-health/prospera-organ-transplantation-assessment/patients/) - [Prospera for Heart Patients](https://www.natera.com/organ-health/prospera-heart-transplantation-assessment/patients/) - [Prospera for Lung Patients](https://www.natera.com/organ-health/prospera-lung-transplantation-assessment/patients/) - [Renasight Patient Information](https://www.natera.com/organ-health/renasight-genetic-testing/patients/) - [Pricing and Billing Information](https://www.natera.com/organ-health/organ-health-pricing-billing/) - 

Signatera by Natera is a personalized MRD test for detecting and monitoring cancer using circulating tumor DNA analysis.

Signatera

Signatera is a highly sensitive, personalized MRD test that detects circulating tumor DNA (ctDNA) in the blood. It is tailored to the unique genetic makeup of an individual's tumor, allowing for the early detection of cancer recurrence and the monitoring of treatment response. This non-invasive test offers a way to identify minimal residual disease with high precision, providing valuable insights for personalized treatment planning.

Signatera

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact